PRCT logo

PROCEPT BioRobotics (PRCT) Depreciation and amortization

annual D&A:

$5.23M+$1.43M(+37.48%)
December 31, 2024

Summary

  • As of today (July 6, 2025), PRCT annual depreciation & amortization is $5.23 million, with the most recent change of +$1.43 million (+37.48%) on December 31, 2024.
  • During the last 3 years, PRCT annual D&A has risen by +$1.91 million (+57.46%).
  • PRCT annual D&A is now at all-time high.

Performance

1-year change

+37.48%

3-year change

+57.46%

5-year change

+250.33%

15-year change

+250.33%

PRCT Depreciation and amortization Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

63.24%
PRCT annual depreciation & amortization is higher than 63.24% of companies in Healthcare sector

Range

All-time high

$5.23M
PRCT annual depreciation & amortization is currently at an all-time high

3-year low

$2.84M
PRCT annual depreciation & amortization is currently +84.23% above its 3-year low

Earnings dates

Last annual earnings report date

Dec 31, 2024
PRCT previous annual earnings announcement was published on Dec 31, 2024

Next annual earnings report date

N/A
PRCT next annual earnings announcement has not yet been scheduled

OtherPRCTincome statement metrics

Annual total expenses

$321.11M
PRCT annual total expenses is $321.11 million

annual operating expenses

$233.71M
PRCT annual total operating expenses is $233.71 million

annual cost of goods sold

$87.40M
PRCT annual cost of goods sold is $87.40 million

annual interest expense

$4.18M
PRCT annual interest expense is $4.18 million

quarterly D&A:

$1.48M+$22.00K(+1.51%)
March 1, 2025

Summary

  • As of today (July 6, 2025), PRCT quarterly depreciation & amortization is $1.48 million, with the most recent change of +$22.00 thousand (+1.51%) on March 1, 2025.
  • Over the past year, PRCT quarterly D&A has increased by +$291.00 thousand (+24.58%).
  • PRCT quarterly D&A is now at all-time high.

Performance

3-month change

+1.51%

1-year change

+24.58%

3-year change

+94.59%

5-year change

-

PRCT quarterly D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

63.73%
PRCT quarterly depreciation & amortization is higher than 63.73% of companies in Healthcare sector

Range

All-time high

$1.48M
PRCT quarterly depreciation & amortization is currently at an all-time high

3-year low

$642.00K
PRCT quarterly depreciation & amortization is currently +129.75% above its 3-year low

Earnings dates

Last quarterly earnings report date

Mar 1, 2025
PRCT previous earnings announcement was published on Mar 1, 2025

Next quarterly earnings report date

Aug 1, 2025
PRCT next earnings announcement is scheduled for Aug 1, 2025

OtherPRCTincome statement metrics

Quarterly total expenses

$96.60M
PRCT quarterly total expenses is $96.60 million

quarterly operating expenses

$71.60M
PRCT quarterly total operating expenses is $71.60 million

quarterly cost of goods sold

$25.00M
PRCT quarterly cost of goods sold is $25.00 million

quarterly interest expense

$877.00K
PRCT quarterly interest expense is $877.00 thousand

TTM D&A:

$5.53M+$291.00K(+5.56%)
March 1, 2025

Summary

  • As of today (July 6, 2025), PRCT TTM depreciation & amortization is $5.53 million, with the most recent change of +$291.00 thousand (+5.56%) on March 1, 2025.
  • Over the past year, PRCT TTM D&A has increased by +$1.33 million (+31.61%).
  • PRCT TTM D&A is now at all-time high.

Performance

3-month change

+5.56%

1-year change

+31.61%

3-year change

+74.46%

5-year change

-

PRCT TTM D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector rank

62.71%
PRCT TTM depreciation & amortization is higher than 62.71% of companies in Healthcare sector

Range

All-time high

$5.53M
PRCT TTM depreciation & amortization is currently at an all-time high

3-year low

$2.80M
PRCT TTM depreciation & amortization is currently +97.25% above its 3-year low

Earnings dates

Last quarterly earnings report date

Mar 1, 2025
PRCT previous earnings announcement was published on Mar 1, 2025

Next quarterly earnings report date

Aug 1, 2025
PRCT next earnings announcement is scheduled for Aug 1, 2025

OtherPRCTincome statement metrics

Annual total expenses

$321.11M
PRCT annual total expenses is $321.11 million

annual operating expenses

$233.71M
PRCT annual total operating expenses is $233.71 million

TTM cost of goods sold

$92.89M
PRCT TTM cost of goods sold is $92.89 million

TTM interest expense

$4.02M
PRCT TTM interest expense is $4.02 million

PRCT Depreciation and amortization Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+37.5%+24.6%+31.6%
3 y3 years+57.5%+94.6%+74.5%
5 y5 years+250.3%--

PRCT Depreciation and amortization Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+84.2%at high+129.8%at high+97.3%
5 y5-yearat high+250.3%at high+129.8%at high+503.8%
alltimeall timeat high+250.3%at high+129.8%at high+503.8%

PRCT Depreciation and amortization History

DateAnnualQuarterlyTTM
Mar 2025
-
$1.48M(+1.5%)
$5.53M(+5.6%)
Dec 2024
$5.23M(+37.5%)
$1.45M(+9.4%)
$5.23M(+2.6%)
Sep 2024
-
$1.33M(+4.6%)
$5.10M(+5.7%)
Jun 2024
-
$1.27M(+7.2%)
$4.83M(+14.9%)
Mar 2024
-
$1.18M(-10.2%)
$4.20M(+10.3%)
Dec 2023
$3.81M(+34.0%)
$1.32M(+25.0%)
$3.81M(+20.8%)
Sep 2023
-
$1.05M(+64.2%)
$3.15M(+12.5%)
Jun 2023
-
$642.00K(-19.0%)
$2.80M(-2.6%)
Mar 2023
-
$793.00K(+19.6%)
$2.88M(+1.2%)
DateAnnualQuarterlyTTM
Dec 2022
$2.84M(-14.5%)
$663.00K(-5.7%)
$2.84M(-3.4%)
Sep 2022
-
$703.00K(-2.0%)
$2.94M(-3.1%)
Jun 2022
-
$717.00K(-5.4%)
$3.03M(-4.2%)
Mar 2022
-
$758.00K(-0.7%)
$3.17M(-4.7%)
Dec 2021
$3.32M(+16.2%)
$763.00K(-4.1%)
$3.32M(+29.8%)
Sep 2021
-
$796.00K(-6.4%)
$2.56M(+45.1%)
Jun 2021
-
$850.00K(-7.1%)
$1.76M(+92.9%)
Mar 2021
-
$915.00K
$915.00K
Dec 2020
$2.86M(+91.4%)
-
-
Dec 2019
$1.49M
-
-

FAQ

  • What is PROCEPT BioRobotics annual depreciation & amortization?
  • What is the all time high annual D&A for PROCEPT BioRobotics?
  • What is PROCEPT BioRobotics annual D&A year-on-year change?
  • What is PROCEPT BioRobotics quarterly depreciation & amortization?
  • What is the all time high quarterly D&A for PROCEPT BioRobotics?
  • What is PROCEPT BioRobotics quarterly D&A year-on-year change?
  • What is PROCEPT BioRobotics TTM depreciation & amortization?
  • What is the all time high TTM D&A for PROCEPT BioRobotics?
  • What is PROCEPT BioRobotics TTM D&A year-on-year change?

What is PROCEPT BioRobotics annual depreciation & amortization?

The current annual D&A of PRCT is $5.23M

What is the all time high annual D&A for PROCEPT BioRobotics?

PROCEPT BioRobotics all-time high annual depreciation & amortization is $5.23M

What is PROCEPT BioRobotics annual D&A year-on-year change?

Over the past year, PRCT annual depreciation & amortization has changed by +$1.43M (+37.48%)

What is PROCEPT BioRobotics quarterly depreciation & amortization?

The current quarterly D&A of PRCT is $1.48M

What is the all time high quarterly D&A for PROCEPT BioRobotics?

PROCEPT BioRobotics all-time high quarterly depreciation & amortization is $1.48M

What is PROCEPT BioRobotics quarterly D&A year-on-year change?

Over the past year, PRCT quarterly depreciation & amortization has changed by +$291.00K (+24.58%)

What is PROCEPT BioRobotics TTM depreciation & amortization?

The current TTM D&A of PRCT is $5.53M

What is the all time high TTM D&A for PROCEPT BioRobotics?

PROCEPT BioRobotics all-time high TTM depreciation & amortization is $5.53M

What is PROCEPT BioRobotics TTM D&A year-on-year change?

Over the past year, PRCT TTM depreciation & amortization has changed by +$1.33M (+31.61%)
On this page